Generic GLP-1 launch in US: Q4 2026
71%YES chance
Yes
71%
No
29%
Now 71.1%
Resolution
Resolves to the quarter the first FDA-approved generic GLP-1 (semaglutide or tirzepatide) launches in the US.
Source: https://www.fda.gov/
Resolves by May 23, 2027.
Recent trades
- YES@logantorres86.4 sh@ 71%60 SP
- NO@alexkhan113.1 sh@ 68%34 SP
- YES@tatumchen93.8 sh@ 72%66 SP
- YES@alexalvarez121.3 sh@ 69%80 SP
- NO@wrenvargas42 sh@ 63%15 SP
- YES@drewhayes51.5 sh@ 65%33 SP
- NO@harperyoon187.5 sh@ 63%62 SP
- YES@reesekhan100.4 sh@ 71%69 SP
- YES@drewhayes24.2 sh@ 67%16 SP
- YES@tatumkim76.5 sh@ 66%49 SP
- YES@rileykim135.3 sh@ 62%80 SP
- YES@morgansantos41.9 sh@ 56%23 SP
- NO@taylorvargas74.4 sh@ 54%33 SP
- YES@rileykim60.7 sh@ 57%34 SP
- NO@alexalvarez137.6 sh@ 55%58 SP
- YES@rowanmonroe26.4 sh@ 61%16 SP
- YES@briarlopez122.9 sh@ 60%70 SP
- YES@rowandiaz78.9 sh@ 54%41 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.
Discussion
- @averylopezAvery Lopez8 days ago
could see it either way.